338 related articles for article (PubMed ID: 31993059)
1. Intercellular Adhesion Molecule-1 (ICAM-1) and ICAM-2 Differentially Contribute to Peripheral Activation and CNS Entry of Autoaggressive Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis.
Haghayegh Jahromi N; Marchetti L; Moalli F; Duc D; Basso C; Tardent H; Kaba E; Deutsch U; Pot C; Sallusto F; Stein JV; Engelhardt B
Front Immunol; 2019; 10():3056. PubMed ID: 31993059
[TBL] [Abstract][Full Text] [Related]
2. Sialomucin CD43 regulates T helper type 17 cell intercellular adhesion molecule 1 dependent adhesion, apical migration and transendothelial migration.
Velázquez FE; Anastasiou M; Carrillo-Salinas FJ; Ngwenyama N; Salvador AM; Nevers T; Alcaide P
Immunology; 2019 May; 157(1):52-69. PubMed ID: 30690734
[TBL] [Abstract][Full Text] [Related]
3. Cell surface levels of endothelial ICAM-1 influence the transcellular or paracellular T-cell diapedesis across the blood-brain barrier.
Abadier M; Haghayegh Jahromi N; Cardoso Alves L; Boscacci R; Vestweber D; Barnum S; Deutsch U; Engelhardt B; Lyck R
Eur J Immunol; 2015 Apr; 45(4):1043-58. PubMed ID: 25545837
[TBL] [Abstract][Full Text] [Related]
4. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
5. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System.
Dusi S; Angiari S; Pietronigro EC; Lopez N; Angelini G; Zenaro E; Della Bianca V; Tosadori G; Paris F; Amoruso A; Carlucci T; Constantin G; Rossi B
Front Immunol; 2019; 10():2436. PubMed ID: 31681316
[TBL] [Abstract][Full Text] [Related]
6. IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis.
Yan Y; Zhang GX; Gran B; Fallarino F; Yu S; Li H; Cullimore ML; Rostami A; Xu H
J Immunol; 2010 Nov; 185(10):5953-61. PubMed ID: 20944000
[TBL] [Abstract][Full Text] [Related]
7. 4-Ethylguaiacol modulates neuroinflammation and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis.
Weng WT; Kuo PC; Brown DA; Scofield BA; Furnas D; Paraiso HC; Wang PY; Yu IC; Yen JH
J Neuroinflammation; 2021 May; 18(1):110. PubMed ID: 33975618
[TBL] [Abstract][Full Text] [Related]
8. The action of TH17 cells on blood brain barrier in multiple sclerosis and experimental autoimmune encephalomyelitis.
Balasa R; Barcutean L; Balasa A; Motataianu A; Roman-Filip C; Manu D
Hum Immunol; 2020 May; 81(5):237-243. PubMed ID: 32122685
[TBL] [Abstract][Full Text] [Related]
9. Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.
Lee MJ; Jang M; Choi J; Chang BS; Kim DY; Kim SH; Kwak YS; Oh S; Lee JH; Chang BJ; Nah SY; Cho IH
Mol Neurobiol; 2016 Apr; 53(3):1977-2002. PubMed ID: 25846819
[TBL] [Abstract][Full Text] [Related]
10. STEAP4 expression in CNS resident cells promotes Th17 cell-induced autoimmune encephalomyelitis.
Zhao J; Liao Y; Miller-Little W; Xiao J; Liu C; Li X; Li X; Kang Z
J Neuroinflammation; 2021 Apr; 18(1):98. PubMed ID: 33879167
[TBL] [Abstract][Full Text] [Related]
11. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
Kong W; Li H; Tuma RF; Ganea D
Cell Immunol; 2014 Jan; 287(1):1-17. PubMed ID: 24342422
[TBL] [Abstract][Full Text] [Related]
12. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
13. Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.
Cummings M; Arumanayagam ACS; Zhao P; Kannanganat S; Stuve O; Karandikar NJ; Eagar TN
PLoS One; 2018; 13(8):e0200752. PubMed ID: 30089166
[TBL] [Abstract][Full Text] [Related]
14. Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
Álvarez-Sánchez N; Cruz-Chamorro I; López-González A; Utrilla JC; Fernández-Santos JM; Martínez-López A; Lardone PJ; Guerrero JM; Carrillo-Vico A
Brain Behav Immun; 2015 Nov; 50():101-114. PubMed ID: 26130320
[TBL] [Abstract][Full Text] [Related]
15. ALCAM (CD166) is involved in extravasation of monocytes rather than T cells across the blood-brain barrier.
Lyck R; Lécuyer MA; Abadier M; Wyss CB; Matti C; Rosito M; Enzmann G; Zeis T; Michel L; García Martín AB; Sallusto F; Gosselet F; Deutsch U; Weiner JA; Schaeren-Wiemers N; Prat A; Engelhardt B
J Cereb Blood Flow Metab; 2017 Aug; 37(8):2894-2909. PubMed ID: 28273717
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
[TBL] [Abstract][Full Text] [Related]
17. IKKβ-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1/Th17 cell activation and compromising blood brain barrier.
Lee MJ; Bing SJ; Choi J; Jang M; Lee G; Lee H; Chang BS; Jee Y; Lee SJ; Cho IH
Mol Neurodegener; 2016 Jul; 11(1):54. PubMed ID: 27450563
[TBL] [Abstract][Full Text] [Related]
18. Epinephrine Production in Th17 Cells and Experimental Autoimmune Encephalitis.
Yang P; Tian H; Zou YR; Chambon P; Ichinose H; Honig G; Diamond B; Kim SJ
Front Immunol; 2021; 12():616583. PubMed ID: 33692790
[TBL] [Abstract][Full Text] [Related]
19. Caveolin1 Is Required for Th1 Cell Infiltration, but Not Tight Junction Remodeling, at the Blood-Brain Barrier in Autoimmune Neuroinflammation.
Lutz SE; Smith JR; Kim DH; Olson CVL; Ellefsen K; Bates JM; Gandhi SP; Agalliu D
Cell Rep; 2017 Nov; 21(8):2104-2117. PubMed ID: 29166603
[TBL] [Abstract][Full Text] [Related]
20. Dulaglutide Modulates the Development of Tissue-Infiltrating Th1/Th17 Cells and the Pathogenicity of Encephalitogenic Th1 Cells in the Central Nervous System.
Chiou HC; Lin MW; Hsiao PJ; Chen CL; Chiao S; Lin TY; Chen YC; Wu DC; Lin MH
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
